You are currently logged into
POZ Directory - My Account or Log Out
POZ POZ
  • Home
  • Basics
    • Basics
    • Introduction
    • HIV Transmission and Risks
    • HIV Testing
    • HIV Prevention
    • Newly Diagnosed
    • Starting HIV Treatment
    • HIV Medications
    • HIV Drug Assistance Programs
    • HIV/HCV Coinfection
    • VIH/SIDA en Español
  • News
    • News
    • Newsfeed
    • Treatment News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Videos
    • POZ TV
    • POZ Stories
    • POZ 100
    • By Author
    • RSS Links
  • Hot Topics
    • Hot Topics
    • World AIDS Day
    • POZ Awards
    • POZ at 25
    • POZ 100
    • Advocacy
    • Cure
    • Undetectable (U=U)
    • Prevention
    • PrEP
    • Criminalization
    • Newly Diagnosed
    • Long-Term Survivors
    • Youth
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • POZ Focus
    • Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Community
    • POZ Personals
    • POZ Stories
    • POZ 100
    • Community
    • AIDS Is Everyday
    • Forums
    • Polls
    • Surveys
    • Quizzes
    • Ask POZ
    • Services Directory
    • Calendar
    • Jobs
    • Bookstore
  • About Us
    • About Us
    • About Us
    • Masthead
    • Awards
    • Press Releases
    • Advertise
    • Contact Us
  • Facebook
  • Twitter

© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2019 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#Opdivo

Tweet
  • Share

T cells attack a cancer cell

People With HIV Can Benefit From Cancer Immunotherapy

Treatment with checkpoint inhibitors appears safe and effective for HIV-positive people.

Cancer cells and lymphocytes

Immunotherapy Shows Promise for HIV-Related Kaposi Sarcoma

Six out of nine patients experienced cancer remission with Opdivo or Keytruda.

Cancer Immune Therapy Causes “Drastic Decrease” in HIV Reservoir

A case study of a 51-year-old man treated for lung cancer reveals a promising avenue toward possibly curing the virus.

Monsef Benkirane, MD, at IAS HIV Cure and Cancer Forum

Cancer Research May Offer Clues to an HIV Cure—and Vice Versa

Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.